Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Novoron Bioscience develops novel therapeutic approaches for the treatment of disorders of the central nervous system. The company has made proprietary scientific discoveries in treatment of various pathologies of the central nervous system and is advancing a pipeline of biologic therapeutics for multiple sclerosis, spinal cord injury and glaucoma. Novoron is a Delaware C-corp headquartered in San Diego, California and is part of the JLABS innovation community.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 28, 2022 | Grant | — | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |